The Legal Examiner Affiliate Network The Legal Examiner The Legal Examiner The Legal Examiner search feed instagram google-plus avvo phone envelope checkmark mail-reply spinner error close
Skip to main content
| Childers, Schlueter & Smith

The FDA has announced that the popular asthma medications Advair and Serevent will now contain a new “black box” warning after discovering the medications may cause an increased risk of asthma-related death. Black box warnings are the most severe warnings the FDA can require of prescription drugs.

According to

Advair should be used only by patients when other asthma drugs, such as low- to medium-dose inhaled corticosteroids, don’t work or if their asthma is severe enough to merit use of two medications, the revised warning says.

As for Serevent, it should only be used as an additional medication when the low- to medium-dose inhaled corticosteroids aren’t sufficient or, again, if the asthma is serious enough to merit use of two drugs.

More information on the Advair and Serevent

Comments are closed.